Jpmorgan Chase & CO Spruce Biosciences, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SPRB
# of Institutions
6Shares Held
6.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$323 Million20.39% of portfolio
-
Abingworth LLP London, X01.79MShares$197 Million0.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$115 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1MShares$110 Million0.02% of portfolio
-
Black Rock Inc. New York, NY125KShares$13.7 Million0.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $2.59B
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...